Acromegaly Pipeline Analysis 2018 - Focusing On Clinical Trials And Results, Drug Profiling, Patents, Collaborations, And Other Recent Developments
- Published : Mar 2020
- Report Code : KSI061611419
- Pages : 114
Offered with this report
Market Data and Estimates in Excel
2 Months of Post Sale Analyst Support
Requirement Specific Customization
Acromegaly Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.
Acromegaly Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Acromegaly is a rare hormonal disorder where there is an excess amount of growth hormone (GH) in the human body leading to the formation of enlarged bone structure and children can grow to abnormal heights. Physical changes in a patient suffering from acromegaly are gradual and if not treated at the right time may be life-threatening as well. The disease usually affects the face, arms and legs.
The report provides acromegaly treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Ionis Pharmaceuticals, Inc., Novartis AG, Aquestive Therapeutics, Peptron, and Ipsen among others.
Scope:
By Company
By Phase
By Molecule Type
By Region
By Route of Administration
1. Introduction
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region
2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology
3. Executive Summary
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
• Drug Name
• Generic Name
• Synonyms
• Company
• Collaborator
• Route of administration
• Target
• Mechanism of Action
• Technology
• Molecule type
• CAS Number
• Weight
• Chemical Formula
• IUPAC name
• ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region
6. Company profiling
6.1. Ipsen
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.2. Novartis AG
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.3. Chiasma, Inc.
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.4. Strongbridge Biopharma plc
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.5. Aspireo Pharmaceuticals Limited
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
6.6. ITALFARMACO S.p.A.
6.6.1. Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.7. CRINETICS PHARMACEUTICALS
6.7.1. Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.8. Camurus AB
6.8.1. Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
6.9. Amryt Pharma plc
6.9.1. Introduction
6.9.2. Financials
6.9.3. Products and Services
6.9.4. SWOT
6.10. Antisense Therapeutics Limited
6.10.1. Introduction
6.10.2. Financials
6.10.3. Products and Services
6.10.4. SWOT
6.11. Midatech Pharma PLC
6.11.1. Introduction
6.11.2. Financials
6.11.3. Products and Services
6.11.4. SWOT
6.12. TTY Biopharm
6.12.1. Introduction
6.12.2. Financials
6.12.3. Products and Services
6.12.4. SWOT
6.13. Foresee Pharmaceuticals Co., Ltd.
6.13.1. Introduction
6.13.2. Financials
6.13.3. Products and Services
6.13.4. SWOT
6.14. Bachem
6.14.1. Introduction
6.14.2. Financials
6.14.3. Products and Services
6.14.4. SWOT
6.15. Peptron
6.15.1. Introduction
6.15.2. Financials
6.15.3. Products and Services
6.15.4. SWOT
6.16. Aegis Therapeutics, LLC
6.16.1. Introduction
6.16.2. Financials
6.16.3. Products and Services
6.16.4. SWOT
6.17. Aquestive Therapeutics
6.17.1. Introduction
6.17.2. Financials
6.17.3. Products and Services
6.17.4. SWOT
6.18. Dauntless Pharmaceuticals
6.18.1. Introduction
6.18.2. Financials
6.18.3. Products and Services
6.18.4. SWOT
6.19. DexTech Medical AB
6.19.1. Introduction
6.19.2. Financials
6.19.3. Products and Services
6.19.4. SWOT
6.20. Ionis Pharmaceuticals, Inc.
6.20.1. Introduction
6.20.2. Financials
6.20.3. Products and Services
6.20.4. SWOT
6.21. leon-nanodrugs GmbH
6.21.1. Introduction
6.21.2. Financials
6.21.3. Products and Services
6.21.4. SWOT
6.22. Silence Therapeutics
6.22.1. Introduction
6.22.2. Financials
6.22.3. Products and Services
6.22.4. SWOT
List of Tables
List of Figures
Ipsen
Novartis AG
Chiasma, Inc.
Strongbridge Biopharma plc
Aspireo Pharmaceuticals Limited
ITALFARMACO S.p.A.
CRINETICS PHARMACEUTICALS
Camurus AB
Amryt Pharma plc
Antisense Therapeutics Limited
Midatech Pharma PLC
TTY Biopharm
Foresee Pharmaceuticals Co., Ltd.
Bachem
Peptron
Aegis Therapeutics, LLC
Aquestive Therapeutics
Dauntless Pharmaceuticals
DexTech Medical AB
Ionis Pharmaceuticals, Inc.
leon-nanodrugs GmbH
Silence Therapeutics
Related Reports
| Report Name | Published Month | Get Sample PDF |
|---|---|---|
| Epidermolysis Bullosa Care and Treatment Market Size: 2021 - 2026 | May 2021 | |
| Pipeline Security Market Size & Share: Industry Report, 2021 - 2026 | May 2021 | |
| Hemochromatosis (Iron Overload) Pipeline Analysis 2018 (Q1) | Industry Report | Forecasts till 2024 | Mar 2020 | |
| Merkel Cell Carcinoma Pipeline Analysis 2019 (H1) | Mar 2020 | |
| Eosinophilic Esophagitis Pipeline Analysis 2019 (H1) | Mar 2020 |